vs
Side-by-side financial comparison of Doximity, Inc. (DOCS) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $185.1M, roughly 1.1× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs 2.7%, a 30.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 9.8%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 25.2%).
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
DOCS vs IRTC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.1M | $208.9M |
| Net Profit | $61.6M | $5.6M |
| Gross Margin | 89.9% | 70.9% |
| Operating Margin | 38.9% | 1.1% |
| Net Margin | 33.3% | 2.7% |
| Revenue YoY | 9.8% | 27.1% |
| Net Profit YoY | -18.1% | 518.5% |
| EPS (diluted) | $0.31 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.1M | $208.9M | ||
| Q3 25 | $168.5M | $192.9M | ||
| Q2 25 | $145.9M | $186.7M | ||
| Q1 25 | $138.3M | $158.7M | ||
| Q4 24 | $168.6M | $164.3M | ||
| Q3 24 | $136.8M | $147.5M | ||
| Q2 24 | $126.7M | $148.0M | ||
| Q1 24 | $118.1M | $131.9M |
| Q4 25 | $61.6M | $5.6M | ||
| Q3 25 | $62.1M | $-5.2M | ||
| Q2 25 | $53.3M | $-14.2M | ||
| Q1 25 | $62.5M | $-30.7M | ||
| Q4 24 | $75.2M | $-1.3M | ||
| Q3 24 | $44.2M | $-46.2M | ||
| Q2 24 | $41.4M | $-20.1M | ||
| Q1 24 | $40.6M | $-45.7M |
| Q4 25 | 89.9% | 70.9% | ||
| Q3 25 | 90.3% | 71.1% | ||
| Q2 25 | 89.2% | 71.2% | ||
| Q1 25 | 89.5% | 68.8% | ||
| Q4 24 | 91.6% | 70.0% | ||
| Q3 24 | 90.0% | 68.8% | ||
| Q2 24 | 89.3% | 69.9% | ||
| Q1 24 | 89.4% | 66.3% |
| Q4 25 | 38.9% | 1.1% | ||
| Q3 25 | 37.8% | -4.4% | ||
| Q2 25 | 37.4% | -10.0% | ||
| Q1 25 | 35.2% | -20.5% | ||
| Q4 24 | 47.4% | -2.5% | ||
| Q3 24 | 38.8% | -34.1% | ||
| Q2 24 | 36.4% | -15.5% | ||
| Q1 24 | 35.5% | -28.9% |
| Q4 25 | 33.3% | 2.7% | ||
| Q3 25 | 36.8% | -2.7% | ||
| Q2 25 | 36.5% | -7.6% | ||
| Q1 25 | 45.2% | -19.3% | ||
| Q4 24 | 44.6% | -0.8% | ||
| Q3 24 | 32.3% | -31.3% | ||
| Q2 24 | 32.7% | -13.6% | ||
| Q1 24 | 34.4% | -34.6% |
| Q4 25 | $0.31 | $0.18 | ||
| Q3 25 | $0.31 | $-0.16 | ||
| Q2 25 | $0.27 | $-0.44 | ||
| Q1 25 | $0.31 | $-0.97 | ||
| Q4 24 | $0.37 | $-0.03 | ||
| Q3 24 | $0.22 | $-1.48 | ||
| Q2 24 | $0.21 | $-0.65 | ||
| Q1 24 | $0.20 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.8M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $979.3M | $152.7M |
| Total Assets | $1.2B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.8M | $583.8M | ||
| Q3 25 | $169.2M | $565.2M | ||
| Q2 25 | $137.3M | $545.5M | ||
| Q1 25 | $209.6M | $520.6M | ||
| Q4 24 | $165.3M | $535.6M | ||
| Q3 24 | $184.2M | $522.0M | ||
| Q2 24 | $111.4M | $561.5M | ||
| Q1 24 | $96.8M | $569.1M |
| Q4 25 | $979.3M | $152.7M | ||
| Q3 25 | $1.1B | $121.9M | ||
| Q2 25 | $1.0B | $103.7M | ||
| Q1 25 | $1.1B | $86.7M | ||
| Q4 24 | $1.0B | $90.9M | ||
| Q3 24 | $961.2M | $71.8M | ||
| Q2 24 | $913.6M | $99.2M | ||
| Q1 24 | $901.4M | $90.3M |
| Q4 25 | $1.2B | $1.0B | ||
| Q3 25 | $1.3B | $995.2M | ||
| Q2 25 | $1.2B | $964.0M | ||
| Q1 25 | $1.3B | $926.1M | ||
| Q4 24 | $1.2B | $931.4M | ||
| Q3 24 | $1.1B | $909.7M | ||
| Q2 24 | $1.1B | $919.2M | ||
| Q1 24 | $1.1B | $909.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.9M | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 0.99× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | $26.2M | ||
| Q3 25 | $93.9M | $34.9M | ||
| Q2 25 | $62.1M | $27.7M | ||
| Q1 25 | $98.5M | $-7.9M | ||
| Q4 24 | $65.2M | $19.2M | ||
| Q3 24 | $68.3M | $24.3M | ||
| Q2 24 | $41.2M | $11.8M | ||
| Q1 24 | $63.9M | $-52.0M |
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $-61.8M |
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -46.8% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | 0.0% | 5.9% | ||
| Q4 24 | 0.0% | 4.2% | ||
| Q3 24 | 0.0% | 6.0% | ||
| Q2 24 | 0.0% | 5.7% | ||
| Q1 24 | 0.0% | 7.4% |
| Q4 25 | 0.99× | 4.70× | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 1.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
